Innovation within a university setting.

Elisabeth K. Wynne, MD, completed her undergraduate degree in bioengineering and is currently a surgical resident in training at the University of Washington. From 2014-2016, she served as a Biodesign Fellow at Stanford University. She plans to pursue a career of innovation as an academic surgeon. Thomas M. Krummel, MD, is the Emile Holman Professor and Chair Emeritus of the Department of Surgery at Stanford University School of Medicine. Throughout his career, Dr Krummel has been a pioneer and an innovator. For >12 years, he has partnered with Dr Paul Yock to co-direct the Stanford Biodesign program, which is designed to teach innovation at the emerging frontiers of engineering and biomedical sciences. Dr Krummel is Chairman of the Fogarty Institute for Innovation Board of Directors, and President of the International Scientific Committee at Institut de Recherche contre les Cancers de l'Appareil Digestif - IRCAD at the University of Strasbourg and is a frequent consultant to the medical device industry.

[1]  T. Krummel,et al.  Intellectual property and royalty streams in academic departments: myths and realities. , 2008, Surgery.

[2]  Guy Kawasaki The Art of the Start: The Time-Tested, Battle-Hardened Guide for Anyone Starting Anything , 2004 .

[3]  T. Stossel Regulation of Financial Conflicts of Interest in Medical Practice and Medical Research: A Damaging Solution in Search of a Problem , 2007, Perspectives in biology and medicine.

[4]  Toni C Antonucci Teams Do It Better! , 2015, Research in human development.

[5]  E. Leuthardt Developing a new model for the invention and translation of neurotechnologies in academic neurosurgery. , 2013, Neurosurgery.

[6]  Charles E. Eesley,et al.  Impact: Stanford University's Economic Impact via Innovation and Entrepreneurship , 2017 .

[7]  S. Agrawal,et al.  The Physician Payments Sunshine Act--Two Years of the Open Payments Program. , 2016, The New England journal of medicine.

[8]  William M. Tierney,et al.  Industry Support of Medical Research: Important Opportunity or Treacherous Pitfall? , 2016, Journal of General Internal Medicine.

[9]  Peter H. Schwartz,et al.  Benchmarks for ethically credible partnerships between industry and academic health centers: beyond disclosure of financial conflicts of interest , 2015, Clinical and Translational Medicine.

[10]  Hugh Silk,et al.  Being Mortal: Medicine and What Matters in the End. , 2016, Family medicine.

[11]  Kevin C. Wooten,et al.  Evolution of Multidisciplinary Translational Teams (MTTs): Insights for Accelerating Translational Innovations , 2015, Clinical and translational science.

[12]  Thomas M Krummel Try again. Fail again. Fail better. , 2015, Journal of pediatric surgery.

[13]  Paul J. Wang,et al.  Outcomes from a Postgraduate Biomedical Technology Innovation Training Program: The First 12 Years of Stanford Biodesign , 2013, Annals of Biomedical Engineering.

[14]  T. Krummel,et al.  Biodesign process and culture to enable pediatric medical technology innovation. , 2015, Seminars in pediatric surgery.

[15]  T. Krummel Inventing our future: training the next generation of surgeon innovators. , 2009, Journal of pediatric surgery.

[16]  F D Moore,et al.  Three ethical revolutions: ancient assumptions remodeled under pressure of transplantation. , 1988, Transplantation proceedings.